chimera, in genetics, an organism or tissue that contains at least two different sets of DNA, most often originating from the fusion of as many different zygotes (fertilized eggs). The term is derived from the Chimera of Greek mythology, a fire-breathing monster that was part lion, part goat, and part dragon. Chimeras are distinguished from mosaics, organisms that contain genetically different populations of cells originating from a single zygote, and from hybrids, organisms containing genetically identical populations of cells originating from a cross of two different species. Included among the different known types of animal chimeras are dispermic and twin chimeras, microchimeras, and parthenogenetic and androgenetic chimeras. (For information on the phenomenon in plants, see chimera.)

In dispermic chimeras, two eggs that have been fertilized by two sperm fuse together, producing a so-called tetragametic individual—an individual originating from four gametes, or sex cells. (Under normal circumstances, in the absence of zygote fusion, two fertilized eggs result in the production of dizygotic, or fraternal, twins.) Dispermic chimerism can also occur when a zygote fuses with a fertilized polar body (a small degenerative cell produced by egg cell division). The different tissues of tetragametic chimeras are made up of cells derived from one or both zygotes; for example, while one tissue type may consist of cells from one zygote, other tissues may consist of cells from the other zygote or may be cellular composites of both zygotes. Indications of tetragametic chimerism include eyes differing in colour, patchwork skin coloration, and ambiguous external genitalia, which is a sign of hermaphroditism (having both male and female reproductive organs). In most instances, however, there are no observable symptoms of tetragametic chimerism, and the condition is detected only through extensive genetic analysis when standard tests, such as histocompatibility testing for tissue matching prior to organ transplantation, turn up unusual results.

When two zygotes do not undergo fusion but exchange cells and genetic material during development, two individuals, or twin chimeras, one or both of whom contain two genetically distinct cell populations, are produced. The most widely known examples of twin chimerism are blood chimeras. These individuals are produced when blood anastomoses (connections) form between the placentas of dizygotic twins, thereby enabling the transfer of stem cells between the developing embryos. When blood chimerism involves male and female twins, female exposure to male hormones results in freemartin syndrome, in which the female is masculinized; this commonly is seen in cattle and rarely in humans. In human blood chimeras of the same sex, chimerism may be detected through routine blood typing, when unexpected results prompt further genetic investigation.

Human microchimeras are produced when fetal stem cells or maternal cells cross the placenta (fetal-maternal microchimerism) or following blood transfusion (transfusion-associated microchimerism) or organ transplantation. The physiological significance of microchimerism is poorly understood. For example, while there is some evidence that it may be associated with delayed hypersensitivity immune responses in fetuses and mothers, other studies have found associations between microchimerism and autoimmune disorders and skin disease.

Other types of chimeras include parthenogenetic and androgenetic chimeras. The former may be produced when a fertilized egg generated through parthenogenesis (a form of asexual reproduction) fuses with a normal zygote. Parthenogenesis in nature generally is limited to lower plants and invertebrates and is prevented in mammals by genomic imprinting (parentally determined gene expression). However, mammalian parthenogenetic chimeras have been developed experimentally and are commonly used for the study of developmental genetics. While human parthenogenetic chimeras seem improbable, scientists reported one such case in 1995.

Androgenetic chimeras are made up of cells that contain the normal combination of maternal and paternal chromosomes and cells that contain two sets of paternal chromosomes (paternal isodisomy). Mammalian androgenetic chimeras generated experimentally rarely survive to birth and often are afflicted by severe developmental disorders. In humans, the condition can occur naturally, though it typically ends in embryonic death. Human androgenetic chimeras appear to arise through the fusion of a normal zygote with an egg that lacks its own nucleus but has been fertilized and contains a duplicate paternal nucleus.

Kara Rogers
Britannica Chatbot logo

Britannica Chatbot

Chatbot answers are created from Britannica articles using AI. This is a beta feature. AI answers may contain errors. Please verify important information using Britannica articles. About Britannica AI.

News

There is progress on GM food crops, says official Mar. 21, 2025, 6:45 AM ET (The Hindu)
Scientists aiming to bring back woolly mammoth create woolly mice Mar. 4, 2025, 3:47 AM ET (The Guardian)

genetic engineering, the artificial manipulation, modification, and recombination of DNA or other nucleic acid molecules in order to modify an organism or population of organisms. The term genetic engineering is generally used to refer to methods of recombinant DNA technology, which emerged from basic research in microbial genetics. The techniques employed in genetic engineering have led to the production of medically important products, including human insulin, human growth hormone, and hepatitis B vaccine, as well as to the development of genetically modified organisms such as disease-resistant plants.

Historical developments

The term genetic engineering initially referred to various techniques used for the modification or manipulation of organisms through the processes of heredity and reproduction. As such, the term embraced both artificial selection and all the interventions of biomedical techniques, among them artificial insemination, in vitro fertilization (e.g., “test-tube” babies), cloning, and gene manipulation. In the latter part of the 20th century, however, the term came to refer more specifically to methods of recombinant DNA technology (or gene cloning), in which DNA molecules from two or more sources are combined either within cells or in vitro and are then inserted into host organisms in which they are able to propagate.

The possibility for recombinant DNA technology emerged with the discovery of restriction enzymes in 1968 by Swiss microbiologist Werner Arber. The following year American microbiologist Hamilton O. Smith purified so-called type II restriction enzymes, which were found to be essential to genetic engineering for their ability to cleave a specific site within the DNA (as opposed to type I restriction enzymes, which cleave DNA at random sites). Drawing on Smith’s work, American molecular biologist Daniel Nathans helped advance the technique of DNA recombination in 1970–71 and demonstrated that type II enzymes could be useful in genetic studies. Genetic engineering based on recombination was pioneered in 1973 by American biochemists Stanley N. Cohen and Herbert W. Boyer, who were among the first to cut DNA into fragments, rejoin different fragments, and insert the new genes into E. coli bacteria, which then reproduced.

Britannica Chatbot logo

Britannica Chatbot

Chatbot answers are created from Britannica articles using AI. This is a beta feature. AI answers may contain errors. Please verify important information using Britannica articles. About Britannica AI.